Prevalence of Fetomaternal Indications of Therapeutic Abortions in Yazd Province

Main Article Content

Sahel Khajehnoori Razieh Sadat Tabatabaee Mahmood Noori-Shadkam Mohammad Hossein Lookzadeh Mahdieh Mojibian Mehdi Mirjalili Nooshin Amjadi Sina Ghasemifar Mahta Mazaheri

Abstract

Background: Therapeutic abortion is defined as intentional termination of pregnancy in order to save the mother’s life and health or when the fetus has an abnormality incompatible with normal life.The aim of this study was to evaluate causes of issuance of therapeutic abortion in women referred to the Yazd province Legal Medicine Organization to terminate the pregnancy.


Methods: In this cross sectional study, all the applications for therapeutic abortions from March 2014 to March 2016 approved by the legal medicine organization of Yazd province were included and recorded. The data was analyzed by SPSS software.


Results: From 333 permissions for abortion during three years ,299 cases (89.8%) were issued for the reason of fetal indications and 34 cases (10.2%) for maternalindications. The most prevalent fetal abnormalities indicated for abortion were central nervous system disorders (especially Anencephaly and Spina Bifida); Hydrops Fetalis and Down syndrome, respectively and the most frequent maternal disorders were cardiovascular diseases.


Conclusion: The current study shows that therapeutic abortions due to fetal abnormalities are increasing. It seems that educating health professionals and people and increasing their awareness about preventing fetal abnormalities and also contraception in women with maternal diseases indicated for abortion could be an effective way to reduce the rate of abortion.


Key words: Therapeutic abortion, Legal medicine organization, Fetal abnormalities, Maternal disorders

Article Details

How to Cite
Khajehnoori, S., Tabatabaee, R. S., Noori-Shadkam, M., Lookzadeh, M. H., Mojibian, M., Mirjalili, M., Amjadi, N., Ghasemifar, S., & Mazaheri, M. (2019, July 29). Prevalence of Fetomaternal Indications of Therapeutic Abortions in Yazd Province. World Journal of Peri and Neonatology, 1-8. Retrieved from http://wjpn.journalonweb.ir/index.php/wjpn/article/view/17
Section
Original Articles

References

1. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap LC, Wenstrom KD. William's obstetrics. 22nd ed. New York, NY: McGraw Hill Professional; 2005.
2. World Health Organization. Unsafe abortion. Geneva: World Health Organization, 2004. [Cited 2005 Oct 20]. Available from: URL; https://apps.who.int/iris/bitstream/handle/10665/42976/9241591803.pdf?sequence=1
3. Larijani B, Zahedi F. Changing parameters for abortion in Iran. Indian J Med Ethics 2006; 3(4): 130-1.
4. Abbasi M, Ahmadi A, Fakoor H. The basics of Therapeutic abortion and its review on the subject of medicallaws. I Medical Law 2012; 6(20): 115-40. [In Persian].
5. Carmona RH. The global challenges of birth defects and disabilities. Lancet 2005; 366(9492): 1142-4.
6. Jahantiq M, Mazaheri M, Rabaninia T, Javaheri A, Amjadi N. Prevalence of Congenital Anomalies in Newborns Zabol. World J Peri & Neonatol 2018; 1(1): 7-14.
7. Fernando S, Bandara T, Sathanantharajah R, Withanaarachchi K. Pattern of clinically recognisable congenital malformations in babies born in a tertiary referral centre in Sri Lanka. Ceylon Med J 2014; 59(4): 132-5.
8. Penchaszadeh VB. Preventing congenital anomalies in developing countries. Community Genet 2002; 5(1): 61-9.
9. Shah I, Ahman E. Unsafe abortion: global and regional incidence, trends, consequences, and challenges. J Obstet Gynaecol Can 2009; 31(12): 1149-58.
10. Sabourin JN, Burnett M. A review of therapeutic abortions and related areas of concern in Canada. J Obstet Gynaecol Can 2012; 34(6): 532-42.
11. Soleimanpour A, Mogharezadeh M, Pourbakhtiar M, Mehmandoust N, Karimi J. The study of legal abortion due to fetal abnormalities in thecases referred to esfahan province forensic medicine centers from 2010 to 2014. Iran J Obstet Gynecol Infertil 2017; 20(4): 25-33. [In Persian].
12. Naeeji H, Mirtorabi SD, Shojamoradi MH, Khatami A. The requests for therapeutic abortion in legal medicine organization of tehran: indications for acceptance and rejection. scientific journal of forensic medicine 2011; Forensic Medicine 2012; 17(1): 41-7. [In Persian].
13. Forouzesh M, Mirhadi SJ, Mohammadi S, JavadiVasigh H, Asadi KH, Tavasoli M, GhaharpourGhatabi M. Investigation of the Abundance Causes of Licensing Therapeutic Abortion by Forensic Medicine Organization and Its Main Determinants in Hormozgan Province during April 2016 until March 2017. Ir J Forensic Med 2017; 23(3): 206-14. [In Persian].
14. Dadipoor S, Safari Moradabadi A, Esmaeelion F, EghbalEftekhaari T, Alavi A, Fallahi S, et al. Prevalence of legal abortions and correlated causes in a central women’s hospital in south of Iran (2009-2012). Life Sci J 2013; 10(12s): 91-4.
15. Ghadi Pasha A, Aminian Z, The study of abortion licences being issued by legal medicine office of kerman in 2005 and a short comparison with last years issued licences. J Kerman Univ Med Sci 2007; 14(2): 147-52. [In Persian].
16. Czeizel AE, Dudás I. Prevention of the first
occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327(26): 1832-5.
17. Riazi H, Bashirian S, Amini L. Awareness of Pregnant Women about Folic Acid Supplementation in Iran. J Fam Reprod Health 2012; 6(4): 159-63.
18. Kim YJ, Lee JE, Kim SH, Shim SS, Cha DH. Maternal age-specific rates of fetal chromosomal abnormalities in Korean pregnant women of advanced maternal age. Obstet Gynecol Sci 2013; 56(3): 160-6.
19. Victor B. Penchaszadeh. Preventing Congenital Anomalies in Developing Countries. Community Genet 2002; 5: 61-69.
20. World Health Organization. Primary health care approaches for prevention and control of congenital and genetic disorders (WHO/HGN/WG/00.1). Geneva, Switzerland: World Health Organization; 2000.